Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation

Dig Liver Dis. 2011 Sep;43(9):754. doi: 10.1016/j.dld.2011.04.022. Epub 2011 Jun 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Benzenesulfonates / adverse effects*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / surgery
  • Fatal Outcome
  • Gastrointestinal Hemorrhage / chemically induced*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / surgery
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Sorafenib
  • Stomach Diseases / chemically induced*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib